Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT03376958 · COMPLETED
Trial details
- NCT number
- NCT03376958
- Sponsor
- Zhengzhou University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2019-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.